Jean‐Marie Leclerc

2.0k total citations
57 papers, 1.1k citations indexed

About

Jean‐Marie Leclerc is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Jean‐Marie Leclerc has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Public Health, Environmental and Occupational Health, 22 papers in Pediatrics, Perinatology and Child Health and 12 papers in Hematology. Recurrent topics in Jean‐Marie Leclerc's work include Acute Lymphoblastic Leukemia research (24 papers), Childhood Cancer Survivors' Quality of Life (15 papers) and Neuroblastoma Research and Treatments (7 papers). Jean‐Marie Leclerc is often cited by papers focused on Acute Lymphoblastic Leukemia research (24 papers), Childhood Cancer Survivors' Quality of Life (15 papers) and Neuroblastoma Research and Treatments (7 papers). Jean‐Marie Leclerc collaborates with scholars based in Canada, United States and Puerto Rico. Jean‐Marie Leclerc's co-authors include David Malkin, Carol Portwine, Joachim Wagner, Caroline Laverdière, Karen R. Rabin, Lucie Jetté, Richard Béliveau, Gérard F. Murphy, Michéle David and Linda Hershon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jean‐Marie Leclerc

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Marie Leclerc Canada	18	320	314	236	231	177	57	1.1k
Samart Pakakasama Thailand	25	334 1.0×	375 1.2×	108 0.5×	408 1.8×	78 0.4×	130	1.6k
Bernard L. Marini United States	18	230 0.7×	120 0.4×	88 0.4×	187 0.8×	57 0.3×	89	914
Mary Morgan United States	16	195 0.6×	118 0.4×	171 0.7×	234 1.0×	49 0.3×	32	1.1k
Manfred Stangl Germany	22	210 0.7×	98 0.3×	497 2.1×	186 0.8×	53 0.3×	104	1.4k
Asim Belgaumi Saudi Arabia	18	305 1.0×	244 0.8×	45 0.2×	293 1.3×	71 0.4×	63	959
David L. Becton United States	26	335 1.0×	134 0.4×	199 0.8×	330 1.4×	87 0.5×	61	1.9k
Petra Glander Germany	26	192 0.6×	249 0.8×	461 2.0×	277 1.2×	62 0.4×	81	2.0k
Biswajit Dubashi India	15	268 0.8×	135 0.4×	98 0.4×	176 0.8×	46 0.3×	131	883
Eun‐Kee Song South Korea	22	623 1.9×	97 0.3×	277 1.2×	183 0.8×	68 0.4×	80	1.4k
José Luís Poveda Spain	18	199 0.6×	180 0.6×	126 0.5×	159 0.7×	20 0.1×	90	922

Countries citing papers authored by Jean‐Marie Leclerc

Since Specialization

Citations

This map shows the geographic impact of Jean‐Marie Leclerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marie Leclerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marie Leclerc more than expected).

Fields of papers citing papers by Jean‐Marie Leclerc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marie Leclerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marie Leclerc. The network helps show where Jean‐Marie Leclerc may publish in the future.

Co-authorship network of co-authors of Jean‐Marie Leclerc

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marie Leclerc. A scholar is included among the top collaborators of Jean‐Marie Leclerc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marie Leclerc. Jean‐Marie Leclerc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Athale, Uma H., Yael Flamand, Traci M. Blonquist, et al.. (2022). Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001. Pediatric Blood & Cancer. 69(8). e29581–e29581. 12 indexed citations

Athale, Uma H., Mäneka Puligandla, Kristen E. Stevenson, et al.. (2018). Outcome of children and adolescents with Down syndrome treated on Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00–001 and 05‐001. Pediatric Blood & Cancer. 65(10). e27256–e27256. 22 indexed citations

Athale, Uma H., Traci M. Blonquist, Kristen E. Stevenson, et al.. (2017). Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001. Blood. 130. 1278–1278. 1 indexed citations

Kahn, Justine M., Peter D. Cole, Traci M. Blonquist, et al.. (2017). An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001. Pediatric Blood & Cancer. 65(3). 23 indexed citations

Mizrahi, Terry, Jean‐Marie Leclerc, Michéle David, Thiérry Ducruet, & Nancy Robitaille. (2015). ABO Group as a Thrombotic Risk Factor in Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 37(5). e328–e332. 24 indexed citations

Mizrahi, Terry, Jean‐Marie Leclerc, Michéle David, Thiérry Ducruet, & Nancy Robitaille. (2013). ABO Group As a Thrombotic Risk Factor In Children With Acute Lymphoblastic Leukemia: A Retrospective Study Of 523 Pediatric Patients. Blood. 122(21). 2370–2370. 2 indexed citations

Andalib, Ali, et al.. (2010). Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Internal Medicine Journal. 42(3). 260–266. 24 indexed citations

Tardif, Jean‐Claude, et al.. (2008). Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4).. PubMed. 15(2). e177–87. 4 indexed citations

Brodeur, Garrett M., A. Thomas Look, Hiroyuki Shimada, et al.. (2001). Biological aspects of neuroblastomas identified by mass screening in quebec. Medical and Pediatric Oncology. 36(1). 157–159. 27 indexed citations

10.

Robaey, Philippe, et al.. (2000). A comprehensive model of the development of mental handicap in children treated for acute lymphoblastic leukaemia: A synthesis of the literature. International Journal of Behavioral Development. 24(1). 44–58. 1 indexed citations

11.

Dubois, Josée, Linda Hershon, Lionel Carmant, et al.. (1999). Toxicity profile of interferon alfa-2b in children: A prospective evaluation. The Journal of Pediatrics. 135(6). 782–785. 81 indexed citations

12.

Coppes, Max J., Rochelle Yanofsky, Sheila Pritchard, et al.. (1999). Safety, Tolerability, Antiemetic Efficacy, and Pharmacokinetics of Oral Dolasetron Mesylate in Pediatric Cancer Patients Receiving Moderately to Highly Emetogenic Chemotherapy. Journal of Pediatric Hematology/Oncology. 21(4). 274–283. 12 indexed citations

13.

Coppes, Max J., Kung Wong Lau, Lewis C. Ingram, et al.. (1999). Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Medical and Pediatric Oncology. 33(2). 99–105. 10 indexed citations

14.

Perrault, Hélène, et al.. (1997). Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline. American Heart Journal. 133(2). 169–173. 36 indexed citations

15.

Jetté, Lucie, Gérard F. Murphy, Jean‐Marie Leclerc, & Richard Béliveau. (1995). Interaction of drugs with P-glycoprotein in brain capillaries. Biochemical Pharmacology. 50(10). 1701–1709. 82 indexed citations

16.

Leclerc, Jean‐Marie, et al.. (1994). Measurement of nucleoside diphosphate kinase—Nm23 activity by anion-exchange high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 660(1). 37–47. 2 indexed citations

17.

Wagner, Joachim, et al.. (1994). High Frequency of Germline p53 Mutations in Childhood Adrenocortical Cancer. JNCI Journal of the National Cancer Institute. 86(22). 1707–1710. 147 indexed citations

18.

Woods, William G., Mendel Tuchman, Mark L. Bernstein, et al.. (1992). Screening for Neuroblastoma in North America. The Pediatric Infectious Disease Journal. 14(4). 312–319. 4 indexed citations

19.

Woods, William G., Mendel Tuchman, Mark L. Bernstein, et al.. (1992). Screening for Neuroblastoma in North America 2-Year Results from the Quebec Project. Journal of Pediatric Hematology/Oncology. 14(4). 312–319. 32 indexed citations

20.

Joncas, J. H., Patrizia Russo, Pierre Brochu, et al.. (1990). Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies.. Journal of Clinical Oncology. 8(3). 378–384. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact